Circulating platelet-neutrophil aggregates play a significant role in Kawasaki disease

Circulation Journal

Volumn 79, Issue 6, 2015, Pages 1349-1356

  Ueno, Kentaro ^a   Nomura, Yuichi ^a   Morita, Yasuko ^b,c   Eguchi, Taisuke ^a   Masuda, Kiminori ^b,c   Kawano, Yoshifumi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Kagoshima City Hospital   (Japan)

^c Kagoshima City Hospital   (Japan)

Author keywords

Coronary artery abnormalities; Kawasaki disease; Platelet neutrophil aggregates; Prednisolone; Vasculitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BETA THROMBOGLOBULIN; C REACTIVE PROTEIN; CD11B ANTIGEN; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; PREDNISOLONE; SODIUM; THROMBOCYTE FACTOR 4; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; IMMUNOSUPPRESSIVE AGENT; PPBP PROTEIN, HUMAN;

ARTICLE; BACTERIAL INFECTION; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEUKOCYTE AGGREGATION; LEUKOCYTE COUNT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RISK ASSESSMENT; SCORING SYSTEM; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; BLOOD; COMPARATIVE STUDY; CORONARY BLOOD VESSEL; DRUG RESISTANCE; ECHOGRAPHY; FEVER; INFANT; NEUTROPHIL; PATHOLOGY; PRESCHOOL CHILD; THROMBOCYTE;

ASPIRIN; BETA-THROMBOGLOBULIN; BLOOD PLATELETS; CHILD, PRESCHOOL; CORONARY VESSELS; DRUG RESISTANCE; FEMALE; FEVER; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEUTROPHILS; PLATELET AGGREGATION INHIBITORS; PLATELET FACTOR 4; PREDNISOLONE;

EID: 84930074630     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-1323     Document Type: Article

References (42)

1. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneus lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974; 54: 271-276.
2. Kato H, Koike S, Yamamoto M, Ito Y, Yano E. Coronary aneurysms in infants and young children with acute febrile mucocutaneus lymph node syndrome. J Pediatr 1975; 86: 892-898.
3. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986; 315: 341-347.
4. Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 2000; 105: E78, doi:10.1542/peds.105.6.e78.
5. Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, et al; RAISE study group investigators. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): A randomised, open-label, blinded-endpoints trial. Lancet 2012; 379: 1613-1620.
6. Shi G, Morrell CN. Platelets as initiators and mediators of inflammation at the vessel wall. Thromb Res 2011; 127: 387-390.
7. Yamamoto T, Chikugo T, Tanaka Y. Elevated plasma levels of betathromboglobulin and platelet factor 4 in patients with rheumatic disorders and cutaneous vasculitis. Clin Rheumatol 2002; 21: 501-504.
8. Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2003; 23: 2131-2137.
9. Von Hundelshausen P, Weber C. Platelets as immune cells: Bridging inflammation and cardiovascular disease. Circ Res 2007; 100: 27-40.
10. Tuttle HA, Davis-Gorman G, Goldman S, Copeland JG, McDonagh PF. Platelet-neutrophil conjugate formation is increased in diabetic women with cardiovascular disease. Cardiovasc Diabetol 2003; 2: 2-12.
11. Gawaz M, Reininger A, Neumann FJ. Platelet function and plateletleukocyte adhesion in symptomatic coronary heart disease: Effects of intravenous magnesium. Thromb Res 1996; 83: 341-349.
12. Lefer AM, Campbell B, Scalia R, Lefer DJ. Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: Role of selectins. Circulation 1998; 98: 1322-1328.
13. Polanowska-Grabowska R, Wallance K, Field JJ, Chen L, Marshall MA, Figler R, et al. P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease. Arterioscler Thromb Vasc Biol 2010; 30: 2392-2399.
14. Levin M, Holland PC, Nokes TJ, Novelli V, Mola M, Levinsky RJ, et al. Platelet immune complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis. Br Med J 1985; 290: 1456-1460.
15. Yahata T, Suzuki C, Yoshioka A, Hamaoka A, Ikeda K. Platelet activation dynamics evaluated using platelet-derived microparticles in Kawasaki disease. Circ J 2013; 78: 188-193.
16. Ueno K, Nomura Y, Hashiguchi T, Masuda K, Morita Y, Hazeki D, et al. Platelet vascular endothelial growth factor is a useful predictor for prognosis in Kawasaki syndrome. Br J Haematol 2010; 148: 85-92.
17. Kobayashi T, Kimura H, Okada Y, Inoue Y, Kobayashi T, Shinohara M, et al. Increased CD11b expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease. Clin Exp Immunol 2007; 148: 112-118.
18. Singbartl K, Green SA, Ley K. Blocking P-selectin protects from ischemia/reperfusion-induced acute renal failure. FASEB J 2000; 14: 48-54.
19. Zarbock A, Singbartl K, Ley K. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest 2006; 116: 3211-3219.
20. Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophilinteractions: Linking hemostasis and inflammation. Blood Rev 2007; 21: 99-111.
21. Liverani E, Banerjee S, Roberts W, Naseem KM, Perretti M. Prednisolone exerts exquisite inhibitory properties on platelet functions. Biochem Pharmacol 2012; 83: 1364-1373.
22. Kato H, Koike S, Yokoyama T. Kawasaki disease: Effect of treatment on coronary artery involvement. Pediatrics 1979; 63: 175-179.
23. Hashino K, Ishii M, Iemura M, Akagi T, Kato H. Re-treatment for immune globulin-resistant Kawasaki disease: A comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int 2001; 43: 211-217.
24. Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al; Kawasaki Disease Research Committee. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 2005; 47: 232-234.
25. JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013): Digest version. Circ J 2014; 78: 2521-2562.
26. Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 2006; 113: 2606-2612.
27. Ogata S, Tremoulet AH, Sato Y, Ueda K, Shimizu C, Sun X, et al. Coronary artery outcomes among children with Kawasaki disease in the United States and Japan. Int J Cardiol 2013; 168: 3825-3828.
28. Wang F, Wang NS, Yan CG, Li JH, Tang LQ. The significance of platelet activation in rheumatoid arthritis. Clin Rheumatol 2007; 26: 768-771.
29. Huo Y, Ley KF. Role of platelets in the development of atherosclerosis. Trends Cardiovasc Med 2004; 14: 18-22.
30. Kirschenbaum LA, Aziz M, Astiz ME, Saha DC, Rackow EC. Influence of rheologic changes and platelet-neutrophil interactions on cell filtration in sepsis. Am J Respir Crit Care Med 2000; 161: 1602-1607.
31. Barnard MR, Krueger LA, Frelinger AL 3rd, Furman MI, Michelson AD. Whole blood analysis of leukocyte-platelet aggregates. Curr Protoc Cytom 2003; Chapter 6: Unit 6.15.
32. Furie B, Furie BC. Leukocyte crosstalk at the vascular wall. Thromb Haemost 1997; 78: 306-309.
33. Li A, Yang F, Dunn S, Gross AK, Smyth SS. Platelets as immune mediators: Their role in host defense responses and sepsis. Thromb Res 2011; 127: 184-188.
34. Kaplan KL, Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indexes of platelet activation in vivo. Blood 1981; 57: 199-202.
35. Suzuki A, Miyagawa-Tomita S, Komatsu K, Nishikawa T, Sakomura Y, Horie T, et al. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: Immunohistochemical study. Circulation 2000; 101: 2935-2941.
36. Nijm J, Wikby A, Tompa A, Olsson AG, Jonasson L. Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease. Am J Cardiol 2005; 95: 452-456.
37. Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9: 61-67.
38. Maugeri N, Brambilla M, Camera M, Carbone A, Tremoli E, Donati MB, et al. Human polymorphonuclear leukocytes produce and express tissue factor upon stimulation. J Thromb Haemost 2006; 4: 1323-1330.
39. del Conde I, Nabi F, Tonda R, Thiagarajan P, Lopez JA, Kleiman NS. Effect of P-selectin on phosphatidylserine exposure and surface dependent thrombin generation on monocytes. Arterioscler Throm Vasc Biol 2005; 25: 1065-1070.
40. Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 2008; 40: 35-42.
41. Moraes LA, Paul-Clark MJ, Rickman A, Flower RJ, Goulding NJ, Perretti M. Ligand-specific glucocorticoid receptor activation in human platelets. Blood 2005; 106: 4167-4175.
42. Okada Y, Shinohara M, Kobayashi T, Inoue Y, Tomomasa T, Kobayashi T, et al. Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J Pediatr 2003; 143: 363-367.